Pharmacophore Mapping Combined with dbCICA Reveal New Structural Features for the Development of Novel Ligands Targeting α4β2 and α7 Nicotinic Acetylcholine Receptors

Pharmacophore Mapping Combined with dbCICA Reveal New Structural Features for the Development of Novel Ligands Targeting α4β2 and α7 Nicotinic Acetylcholine Receptors

The neuronal nicotinic acetylcholine receptors (nAChRs) belong to the ligand-gated ion channel (GLIC) group, presenting a crucial role in several biological processes and neuronal disorders. The α4β2 and α7 nAChRs are the most abundant in the central nervous system (CNS), being involved in challengi...

Full description

Bibliographic Details
Main Authors:	Victor S. Batista, Adriano Marques Gonçalves, Nailton M. Nascimento-Júnior
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Molecules
Subjects:	pharmacophore mapping dbCICA drug design α4β2 nAChRs α7 nAChRs molecular docking
Online Access:	https://www.mdpi.com/1420-3049/27/23/8236

Similar Items

Evaluation of galantamine and deconstructed analogs as α7 nAChR and AChE ligands
by: Malaika D. Argade, et al.
Published: (2022-01-01)

α7 Nicotinic acetylcholine receptor: a key receptor in the cholinergic anti-inflammatory pathway exerting an antidepressant effect
by: Huiyang Liu, et al.
Published: (2023-03-01)

Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas
by: Yujie Shen, et al.
Published: (2022-10-01)

α-Conotoxin TxID and [S9K]TxID, α3β4 nAChR Antagonists, Attenuate Expression and Reinstatement of Nicotine-Induced Conditioned Place Preference in Mice
by: Xiaodan Li, et al.
Published: (2020-12-01)

Unravelling the allosteric binding mode of αD-VxXXB at nicotinic acetylcholine receptors
by: Thao NT Ho, et al.
Published: (2023-04-01)

Venom-Derived Neurotoxins Targeting Nicotinic Acetylcholine Receptors
by: Ayaulym Bekbossynova, et al.
Published: (2021-06-01)

α-Conotoxin TxIB: A Uniquely Selective Ligand for α6/α3β2β3 Nicotinic Acetylcholine Receptor Attenuates Nicotine-Induced Conditioned Place Preference in Mice
by: Shen You, et al.
Published: (2019-08-01)

Residues Responsible for the Selectivity of α-Conotoxins for Ac-AChBP or nAChRs
by: Bo Lin, et al.
Published: (2016-10-01)

Drosophila nicotinic acetylcholine receptor subunits and their native interactions with insecticidal peptide toxins
by: Dagmara Korona, et al.
Published: (2022-05-01)

Targeting α7 nicotinic acetylcholine receptors for chronic pain
by: Ya-Qun Zhou, et al.
Published: (2022-09-01)

αD-Conotoxins in Species of the Eastern Pacific: The Case of <i>Conus princeps</i> from Mexico
by: Arisaí C. Hernández-Sámano, et al.
Published: (2019-07-01)

Advances in small molecule selective ligands for heteromeric nicotinic acetylcholine receptors
by: Carlo Matera, et al.
Published: (2023-08-01)

Small molecule ligands for α9 * and α7 nicotinic receptors: A survey and an update, respectively
by: Alessandro Giraudo, et al.
Published: (2023-07-01)

A Novel α4/7-Conotoxin QuIA Selectively Inhibits α3β2 and α6/α3β4 Nicotinic Acetylcholine Receptor Subtypes with High Efficacy
by: Liujun Wang, et al.
Published: (2022-02-01)

Using Constellation Pharmacology to Characterize a Novel α-Conotoxin from <i>Conus ateralbus</i>
by: Jorge L. B. Neves, et al.
Published: (2024-02-01)

Physiologic Functions and Therapeutic Applications of α7 Nicotinic Acetylcholine Receptor in Brain Disorders
by: Chien-Hsing Lee, et al.
Published: (2022-12-01)

Activation of the α7 Nicotinic Acetylcholine Receptor Prevents against Microglial-Induced Inflammation and Insulin Resistance in Hypothalamic Neuronal Cells
by: Camila Libardi do Amaral, et al.
Published: (2022-07-01)

Target identification and validation of the alpha7 nicotinic acetylcholine receptor as a potential therapeutic target in retinal disease
by: David M. Linn
Published: (2023-07-01)

Nicotinic acetylcholine receptor-mediated effects of varenicline on LPS-elevated prostaglandin and cyclooxygenase levels in RAW 264.7 macrophages
by: Elif Baris, et al.
Published: (2024-05-01)

Differential Modulation of GABAA and NMDA Receptors by an α7-nicotinic Acetylcholine Receptor Agonist in Chronic Glaucoma
by: Xujiao Zhou, et al.
Published: (2017-12-01)

Nicotinic Acetylcholine Receptor Dysfunction in Addiction and in Some Neurodegenerative and Neuropsychiatric Diseases
by: Ana Sofía Vallés, et al.
Published: (2023-08-01)

Rare Missense Variants of the Human β4 Subunit Alter Nicotinic α3β4 Receptor Plasma Membrane Localisation
by: Sara Francesca Colombo, et al.
Published: (2023-01-01)

In silico approaches for developing sesquiterpene derivatives as antagonists of human nicotinic acetylcholine receptors (nAChRs) for nicotine addiction treatment
by: Taufik Muhammad Fakih, et al.
Published: (2025-06-01)

Perspectives on the α5 nicotinic acetylcholine receptor in lung cancer progression
by: Jiaying Cai, et al.
Published: (2025-03-01)

<i>Conus regius</i>-Derived Conotoxins: Novel Therapeutic Opportunities from a Marine Organism
by: Francesco Margiotta, et al.
Published: (2022-12-01)

Activation of α7 Nicotinic Acetylcholine Receptor Upregulates HLA-DR and Macrophage Receptors: Potential Role in Adaptive Immunity and in Preventing Immunosuppression
by: Andrei E. Siniavin, et al.
Published: (2020-03-01)

Toward an Innovative Treatment of Alzheimer’s Disease: Design of MTDLs Targeting Acetylcholinesterase and α-7 Nicotinic Receptors
by: Mégane Pons, et al.
Published: (2019-08-01)

Alanine-Scanning Mutagenesis of α-Conotoxin GI Reveals the Residues Crucial for Activity at the Muscle Acetylcholine Receptor
by: Jiong Ning, et al.
Published: (2018-12-01)

Immunohistochemical detection and regulation of α<sub>5 </sub>nicotinic acetylcholine receptor (nAChR) subunits by FoxA2 during mouse lung organogenesis
by: Willnauer Charles P, et al.
Published: (2011-06-01)

αO-Conotoxin GeXIVA Inhibits the Growth of Breast Cancer Cells via Interaction with α9 Nicotine Acetylcholine Receptors
by: Zhihua Sun, et al.
Published: (2020-04-01)

Recombinant Expression and Characterization of α-Conotoxin LvIA in Escherichia coli
by: Xiaopeng Zhu, et al.
Published: (2016-01-01)

RgIA4 Prevention of Acute Oxaliplatin-Induced Cold Allodynia Requires α9-Containing Nicotinic Acetylcholine Receptors and CD3<sup>+</sup> T-Cells
by: Peter N. Huynh, et al.
Published: (2022-11-01)

SR9883 is a novel small-molecule enhancer of α4β2* nicotinic acetylcholine receptor signaling that decreases intravenous nicotine self-administration in rats
by: Kevin M. Braunscheidel, et al.
Published: (2024-09-01)

Modulation of the Effect of Cisplatin on Nicotine-Stimulated A549 Lung Cancer Cells Using Analog of Marine Sponge Toxin Loaded in Gelatin Nanoparticles
by: Ahmad Joukhan, et al.
Published: (2024-04-01)

Cholinergic signaling via the α7 nicotinic acetylcholine receptor regulates the migration of monocyte-derived macrophages during acute inflammation
by: Kasey R. Keever, et al.
Published: (2024-01-01)

Protective effect of α7 nicotinic acetylcholine receptor activation on experimental colitis and its mechanism
by: Wenyuan Pu, et al.
Published: (2022-09-01)

Roles of alpha-7 nicotinic acetylcholine receptors and spleen in the lung injury induced by a repeated saline lavage in rat
by: Hossein Fatemikia, et al.
Published: (2022-09-01)

Swimming exercise and clove oil can improve memory by molecular responses modification and reduce dark cells in rat model of Alzheimer's disease
by: Z. Gorgin Karaji, et al.
Published: (2023-06-01)

Molecular Regulation of Betulinic Acid on α3β4 Nicotinic Acetylcholine Receptors
by: Shinhui Lee, et al.
Published: (2021-05-01)

Cullin-3 intervenes in muscle atrophy in the elderly by mediating the degradation of nAchRs ubiquitination
by: Jintao Chen, et al.
Published: (2023-11-01)